Renowned nutrition and health researcher Dr. Rhonda Patrick has stepped into a heated scientific debate, offering her perspective on the potential connection between acetaminophen use during pregnancy and autism spectrum disorder in children.
Speaking about a topic she’s followed for over a decade, Dr. Patrick acknowledged the controversial nature of her recent social media post on this subject. “I did a post about this a few days ago. It got a lot of attention,” she noted, She explained that despite discussing this research for years, she’d never received such a strong response from the public.
The researcher was quick to emphasize the preliminary nature of current findings. “This is an association. This is not something that has been established as causation,” she stressed, highlighting the ongoing scientific uncertainty surrounding this potential link.
Multiple studies have suggested concerning patterns, particularly regarding male children. Dr. Patrick explained that research indicates “women that use acetaminophen during pregnancy have a higher risk of having a child with either autism spectrum disorder or ADHD or the behavioral verbal motor delay sort of spectrum” – but crucially, only “if they have a child with autism spectrum disorder that is male but not female.”
This gender disparity appears significant in the research. “It seems as though females are not as vulnerable to this sort of environmental stress, in this case being acetaminophen use,” Dr. Patrick observed.
However, the scientific picture remains complex. A large Swedish study involving 2.5 million participants, published in JAMA, initially found associations between prescribed acetaminophen use and autism risk. Yet when researchers applied sibling analysis – comparing children within the same families – the association disappeared.
Dr. Patrick argues this doesn’t close the case. She points out a critical limitation: “The sibling analysis that was done did not stratify the data according to gender. In other words, the effect of females could dilute out the positive association that’s seen in males.”
Perhaps most compelling in her analysis is biochemical evidence from cord blood studies. “Cord blood acetaminophen levels were measured and then offspring was looked at and whether or not this child was diagnosed with autism spectrum disorder,” she explained. This research revealed a troubling dose-dependent relationship, with mothers in the highest tertile of acetaminophen levels showing “a 3.6 fold higher risk of having a child with autism spectrum disorder compared to people in the lowest tertile.”
This biochemical approach offers advantages over survey-based studies. “We’re not just looking at a prescription. We’re not just relying on a questionnaire asking a mother to try to think back,” Dr. Patrick noted.
Remarkably, the study found acetaminophen present in 100% of samples, suggesting even mothers who reported not using the medication may have been exposed without realizing it.
The researcher emphasized that autism likely results from multiple factors working together. “There are so many different contributing factors, genetics being a big one, epigenetics, maternal infection… immune dysregulation, autoimmunity, as well as vitamin D deficiency,” she explained, also citing environmental factors like plastic chemicals and air pollution.
Rather than advocating for complete avoidance of acetaminophen, Dr. Patrick calls for informed decision-making. “The point is not that we need to make women scared of taking Tylenol during pregnancy,” she clarified. Instead, she believes pregnant women deserve transparent information about potential risks to make informed choices about their medication use.
Her recommendation focuses on thoughtful usage patterns. Such conversations “might really influence the way a woman uses Tylenol during pregnancy… it may change a woman’s use from weekly for any sort of minor ache or pain to perhaps just the last resort.”
Dr. Patrick expressed frustration that this scientific question has become politicized. “It’s become a political issue and it really should not be a red or a blue issue,” she stated. “It should really be an issue about let’s try to understand what all these potential contributing factors to autism spectrum disorder are.”
The researcher advocates for continued investigation rather than premature conclusions. “Just because one or two sibling analysis studies have come out sort of making that association disappear doesn’t mean that it’s not a real association,” she argued. “It just means we don’t understand what’s going on and that we need to continue having conversations around it.”
